Chester County News and Community Website
EXTON, PA — Omega Flex, Inc. (NASDAQ: OFLX) announced its financial results for the first quarter of 2025, reporting a decrease in both net sales and net income compared to …
Omega Flex Reports First Quarter 2025 Earnings Read More
MALVERN, PA — Meridian Corporation (Nasdaq: MRBK) announced first-quarter 2025 results, reporting net income of $2.4 million, slightly below the $2.7 million earned during the same period in 2024. Despite …
Meridian Corporation Reports Q1 2025 Earnings, Declares Quarterly Dividend Read More
WAYNE, PA — Ecovyst Inc. (NYSE: ECVT) has announced a strategic amendment to its existing asset-based lending (ABL) credit agreement through its subsidiary, Ecovyst Catalyst Technologies LLC. The amended facility, valued …
Ecovyst Extends Credit Facility to Improve Financial Flexibility Read More
WAYNE, PA — Palvella Therapeutics, Inc. (Nasdaq: PVLA), a biopharmaceutical company focused on developing treatments for rare genetic skin diseases, has announced its financial results for 2024, alongside key corporate and …
Palvella Therapeutics Reports 2024 Financial Results and Advances Rare Disease Pipeline Read More
MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) has updated its financial results for the fourth quarter and full-year ending December 31, 2024, reflecting revisions related to its acquisition of Greenbrook TMS …
Neuronetics Revises Financial Results for Q4 and Full Year 2024 Read More
MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS) has shared its corporate updates and financial results for the fourth quarter and full year of 2024, highlighting significant advancements in its clinical …
Annovis Bio Reports Progress in Clinical Trials and Improved Financial Position Read More
MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) has reported its financial results for the fourth quarter and full year 2024. The company showcased a year of steady growth and operational …
TELA Bio Announces 2024 Financial Results and Positive 2025 Outlook Read More
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) has reported its financial results for the fourth quarter and full year ending December 31, 2024, marking significant progress in its turnaround …
Verrica Pharmaceuticals Reports Q4 2024 Growth and Pipeline Progress Read More EXTON, PA — Dean W. Rivest, CEO of Omega Flex, Inc. (Nasdaq: OFLX), reported that the company’s net sales for 2024 totaled $101,681,000, compared to $111,465,000 in 2023, reflecting a …
Omega Flex Reports 2024 Financial Results: Sales and Income Decline Amid Market Challenges Read More
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) has reported its fourth-quarter and full-year 2024 financial results, alongside significant progress across its clinical programs and regulatory initiatives. The company continues to drive …
Ocugen Reports 2024 Financial Results and Advances Gene Therapy Programs Read More